Cellestial Health
PrivateLast Round
Seed
Dec 2, 2025
Total Funding Raised
$1.15M
Company Overview
Cellestial Health is a biopharmaceutical company developing small molecule therapeutics designed to slow the progression of neurodegenerative diseases by targeting astrocytes.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellestial Health Comps
Public and private peers based on sector, stage, and business model.
Cellestial Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 2, 2025 | ||||
| Grant | Sep 19, 2025 | ||||
| Pre Seed | May 8, 2025 |
Cellestial Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zinc | Pre Seed |
| Parkinson's UK | Grant |
| Alma Angels | Pre Seed |
| Cambridge Enterprise | Grant |
| SFC Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 8, 2025
$654K raised in Pre Seed round.
Cellestial Health Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cellestial Health's valuation, stock price, and market status.
